The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry

Korean Journal of Internal Medicine

Volumn 29, Issue 6, 2014, Pages 703-712

  Kim, Hyun Kuk ^a   Jeong, Myung Ho ^a   Lee, Seung Hun ^a   Sim, Doo Sun ^a   Hong, Young Joon ^a   Ahn, Youngkeun ^a   Kim, Chong Jin ^b   Cho, Myeong Chan ^c   Kim, Young Jo ^d  

^a Chonnam National University Medical School   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Chungbuk National University Hospital   (South Korea)

^d Yeungnam University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; EVEROLIMUS; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; BARE METAL STENT; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DISEASE REGISTRY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; ELDERLY CARE; FAMILY HISTORY; FIBRINOLYTIC THERAPY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; KIDNEY DYSFUNCTION; LOADING DRUG DOSE; LONG TERM CARE; METABOLIC SYNDROME X; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY PREVENTION; SEX DIFFERENCE; SOUTH KOREA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; EPIDEMIOLOGY; MORTALITY; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; REGISTER; RISK FACTOR; TIME; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

HUMANS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; QUALITY IMPROVEMENT; QUALITY OF HEALTH CARE; REGISTRIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908505897     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2014.29.6.703     Document Type: Review

References (89)

1. Kim HK, Jeong MH, Ahn Y, et al. A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction. Int J Cardiol 2010;145:450-454.
2. Kim HK, Jeong MH, Ahn Y, et al. Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (Korea Acute Myocardial Infarction Registry [KAMIR] score). Am J Cardiol 2011;107:965.e1-971.e1.
3. Kim KH, Kim W, Hwang SH, et al. The CHADSVASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation. J Cardiol 2014 Jun 24 [Epub]. http:// dx.doi.org/10.1016/j.jjcc.2014.04.011.
4. Jeong YW, Jeong MH, Kim SS, et al. CHA2DS2-VASc scoring system as an initial method for screening high-risk patients in acute myocardial infarction. Int J Cardiol 2014;174:777-780.
5. Cho JY, Jeong MH, Ahn Y, et al. Impact of high admission blood pressure without history of hypertension on clinical outcomes of patients with acute myocardial infarction: from Korea Acute Myocardial Infarction Registry. Int J Cardiol 2014;172:e54-e58.
6. Kang DG, Jeong MH, Ahn Y, et al. Clinical effects of hypertension on the mortality of patients with acute myocardial infarction. J Korean Med Sci 2009;24:800-806.
7. Li YJ, Rha SW, Chen KY, et al. Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: lessons from the Korea Acute Myocardial Infarction Registry. Clin Exp Pharmacol Physiol 2010;37:581-586.
8. Kim C, Chang HJ, Cho I, et al. Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry. Korean J Intern Med 2013;28:547-556.
9. Kang SH, Suh JW, Choi DJ, et al. Cigarette smoking is paradoxically associated with low mortality risk after acute myocardial infarction. Nicotine Tob Res 2013;15:1230-1238.
10. Chen KY, Rha SW, Li YJ, et al. ‘Smoker’s paradox’ in young patients with acute myocardial infarction. Clin Exp Pharmacol Physiol 2012;39:630-635.
11. Kang WY, Jeong MH, Ahn YK, et al. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. J Cardiol 2010;55:84-91.
12. Lee SH, Park JS, Kim W, et al. Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry). Am J Cardiol 2008;102:957-965.
13. Park HW, Yoon CH, Kang SH, et al. Early-and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. Int J Cardiol 2013;169:254-261.
14. Song YB, Hahn JY, Kim JH, et al. Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention. Am J Cardiol 2010;106:1397-1403.
15. Kim SS, Jeong MH, Rhew SH, et al. Impact of patients’ arrival time on the care and in-hospital mortality in patients with non-ST-elevation myocardial infarction. Am J Cardiol 2014;113:262-269.
16. Park HE, Koo BK, Lee W, et al. Periodic variation and its effect on management and prognosis of Korean patients with acute myocardial infarction. Circ J 2010;74:970-976.
17. Song YB, Hahn JY, Gwon HC, et al. The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry. J Korean Med Sci 2008;23:357-364.
18. Lee JH, Chae SC, Yang DH, et al. Influence of weather on daily hospital admissions for acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Int J Cardiol 2010;144:16-21.
19. Cho JY, Jeong MH, Ahn YK, et al. Comparison of outcomes of patients with painless versus painful ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2012;109:337-343.
20. Choi JS, Kim CS, Park JW, et al. Renal dysfunction as a risk factor for painless myocardial infarction: results from Korea Acute Myocardial Infarction Registry. Clin Res Cardiol 2012;101:795-803.
21. Kwon TG, Bae JH, Jeong MH, et al. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Int J Cardiol 2009;133:173-178.
22. Kim CS, Kim MJ, Kang YU, et al. Inf luence of renal dysfunction on clinical outcomes in patients with congestive heart failure complicating acute myocardial infarction. Int Heart J 2013;54:304-310.
23. Kang YU, Kim MJ, Choi JS, et al. Concomitant impact of high-sensitivity C-reactive protein and renal dysfunction in patients with acute myocardial infarction. Yonsei Med J 2014;55:132-140.
24. Lee SH, Kim YJ, Kim W, et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ J 2008;72:1410-1418.
25. Seo SM, Kim TH, Kim CJ, et al. Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention. Coron Artery Dis 2012;23:307-314.
26. Sim DS, Ahn Y, Jeong MH, et al. Clinical outcome of unprotected left main coronary artery disease in patients with acute myocardial infarction. Int Heart J 2013;54:185-191.
27. Kim U, Park JS, Kang SW, et al. Outcomes according to presentation with versus without cardiogenic shock in patients with left main coronary artery stenosis and acute myocardial infarction. Am J Cardiol 2012;110:36-39.
28. Baek JY, Seo SM, Park HJ, et al. Clinical outcomes and predictors of unprotected left main stem culprit lesions in patients with acute ST segment elevation myocardial infarction. Catheter Cardiovasc Interv 2014;83:E243-E250.
29. Kim MC, Ahn Y, Rhew SH, et al. Impact of total occlusion of an infarct-related artery on long-term mortality in acute non-ST-elevation myocardial infarction patients who underwent early percutaneous coronary intervention. Int Heart J 2012;53:160-164.
30. Kim SS, Choi HS, Jeong MH, et al. Clinical outcomes of acute myocardial infarction with occluded left circumflex artery. J Cardiol 2011;57:290-296.
31. Kang WY, Jeong MH, Ahn YK, et al. Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe? Int J Cardiol 2011;146:207-212.
32. Jeong HC, Ahn YK, Jeong MH, et al. Intensive pharmacologic treatment in patients with acute non ST-segment elevation myocardial infarction who did not undergo percutaneous coronary intervention. Circ J 2008;72:1403-1409.
33. Choo EH, Chang K, Ahn Y, et al. Benefit of beta-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention. Heart 2014;100:492-499.
34. Jeong HC, Jeong MH, Ahn Y, et al. Comparative assessment of angiotensin II type 1 receptor blockers in the treatment of acute myocardial infarction: surmountable vs. insurmountable antagonist. Int J Cardiol 2014;170:291-297.
35. Jeong HC, Jeong JM, Jeong MH, et al. Effect of single or dual blockade of renin-angiotensin system in acute myocardial infarction patients according to renal function. Int J Cardiol 2012;157:408-411.
36. Kim JS, Kim CH, Chun KJ, et al. Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry. Clin Res Cardiol 2013;102:915-922.
37. Yang MJ, Lee HC, Lee HW, et al. Effect of nicorandil on clinical outcomes in patients with ST-segment elevation and non-ST-segment elevation myocardial infarction: based on the Korea Acute Myocardial Infarction Registry (KAMIR). Int J Cardiol 2013;168:4868-4869.
38. Kim JY, Jeong MH, Moon JH, et al. Impact of Clopidogrel loading dose in patients with chronic kidney disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 2012;110:1598-1606.
39. Choi CU, Rha SW, Oh DJ, et al. Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry. Am Heart J 2011;161:373.e1-3-382.e1-3.
40. Cho JS, Her SH, Baek JY, et al. Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor. J Korean Med Sci 2010;25:1601-1608.
41. Li YJ, Rha SW, Chen KY, et al. Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Am Heart J 2010;159:684.e1-690. e1.
42. Li YJ, Rha SW, Chen KY, et al. Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents. J Cardiol 2012;59:22-29.
43. Sim DS, Jeong MH, Ahn Y, et al. Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2009;103:1333-1338.
44. Sim DS, Jeong MH, Ahn Y, et al. Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction. Am J Cardiol 2012;110:1275-1281.
45. Kim MC, Jeong MH, Ahn Y, et al. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization. Int J Cardiol 2011;153:148-153.
46. Lee HW, Hong TJ, Yang MJ, et al. Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry. Cardiol J 2012;19:256-266.
47. Hong YJ, Jeong MH, Ahn Y, Kang JC. The efficacy and safety of drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction (KAMIR). Int J Cardiol 2013;163:1-4.
48. Sim DS, Jeong MH, Ahn Y, et al. Ef fectiveness of drug-eluting stents versus bare-metal stents in large coronary arteries in patients with acute myocardial infarction. J Korean Med Sci 2011;26:521-527.
49. Bae EH, Lim SY, Choi YH, et al. Drug-eluting vs. bare-metal stents for treatment of acute myocardial infarction with renal insuff iciency: results from Korea Acute Myocardial Infarction Registry. Circ J 2011;75:2798-2804.
50. Lee SR, Jeong MH, Ahn YK, et al. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. Circ J 2008;72:392-398.
51. Cho Y, Yang HM, Park KW, et al. Paclitaxel-versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation. JACC Cardiovasc Interv 2010;3:498-506.
52. Kim HK, Jeong MH, Ahn YK, et al. Comparison of outcomes between Zotarolimus-and sirolimus-eluting stents in patients with ST-segment elevation acute myocardial infarction. Am J Cardiol 2010;105:813-818.
53. Lee MG, Jeong MH, Ahn Y, et al. Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome. Circ J 2011;75:2120-2127.
54. Chen KY, Rha SW, Wang L, et al. Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: a propensity score-matched analysis. JACC Cardiovasc Interv 2012;5:936-945.
55. Cho SC, Jeong MH, Kim W, et al. Clinical outcomes of everolimus-and zotarolimus-eluting stents in patients with acute myocardial infarction for small coronary artery disease. J Cardiol 2014;63:409-417.
56. Ahmed K, Jeong MH, Chakraborty R, et al. Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2011;108:8-14.
57. Hachinohe D, Jeong MH, Saito S, et al. Clinical impact of thrombus aspiration during primary percutaneous coronary intervention: results from Korea Acute Myocardial Infarction Registry. J Cardiol 2012;59:249-257.
58. Lee JH, Yang DH, Park HS, et al. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Am Heart J 2010;159:1012-1019.
59. Lee JH, Park HS, Chae SC, et al. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol 2009;104:182-189.
60. Lee CH, Lee SH, Park JS, et al. Impact of statin usage patterns on outcomes after percutaneous coronary intervention in acute myocardial infarction: Korea Working Group on Myocardial Infarction registry (KorMI) study. J Geriatr Cardiol 2014;11:93-99.
61. Cho KH, Jeong MH, Ahn Y, et al. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox). Am J Cardiol 2010;106:1061-1068.
62. Lee KH, Jeong MH, Kim HM, et al. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol. J Am Coll Cardiol 2011;58:1664-1671.
63. Jeong HC, Ahn Y, Hong YJ, et al. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein. Int J Cardiol 2013;167:1848-1853.
64. Lim SY, Bae EH, Choi JS, et al. Effect on short-and long-term major adverse cardiac events of statin treatment in patients with acute myocardial infarction and renal dysfunction. Am J Cardiol 2012;109:1425-1430.
65. Chen KY, Rha SW, Li YJ, et al. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 2009;119:3207-3214.
66. Choo EH, Kim PJ, Chang K, et al. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality. Coron Artery Dis 2014;25:392-398.
67. Lee KH, Ahn Y, Kim SS, et al. Comparison of triple anti-platelet therapy and dual anti-platelet therapy in patients with acute myocardial infarction who had no-reflow phenomenon during percutaneous coronary intervention. Circ J 2013;77:2973-2981.
68. Korea Acute Myocardial Infarction Registry (KAMIR) Investigators, Lee KH, Jeong MH, et al. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008;130:227-234.
69. Park JS, Kim YJ, Shin DG, et al. Gender differences in clinical features and in-hospital outcomes in ST-segment elevation acute myocardial infarction: from the Korean Acute Myocardial Infarction Registry (KAMIR) study. Clin Cardiol 2010;33:E1-E6.
70. Woo JS, Kim W, Ha SJ, Kim SJ, Kang WY, Jeong MH. Impact of gender differences on long-term outcomes after successful percutaneous coronary intervention in patients with acute myocardial infarction. Int J Cardiol 2010;145:516-518.
71. Kang SH, Suh JW, Yoon CH, et al. Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry). Am J Cardiol 2012;109:787-793.
72. Kim HL, Kang SH, Yoon CH, et al. Differential prognostic impacts of diabetes over time course after acute myocardial infarction. J Korean Med Sci 2013;28:1749-1755.
73. Park KH, Ahn Y, Jeong MH, et al. Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry. Korean J Intern Med 2012;27:180-188.
74. Yang JH, Song PS, Song YB, et al. Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock. Crit Care 2013;17:R218.
75. Lee SA, Cho SJ, Jeong MH, et al. Hypoglycemia at admission in patients with acute myocardial infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in well-controlled patients. Diabetes Care 2014;37:2366-2373.
76. Lee MG, Jeong MH, Ahn Y, et al. Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction. J Korean Med Sci 2010;25:1456-1461.
77. Lee MG, Jeong MH, Ahn Y, et al. Additive impact of diabetes mellitus on patients with metabolic syndrome and acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol 2012;157:283-285.
78. Kim CS, Choi JS, Bae EH, et al. Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction. Metabolism 2013;62:669-676.
79. Ahmed K, Jeong MH, Chakraborty R, et al. Percutaneous coronary intervention with drug-eluting stent implantation vs. coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction. Circ J 2012;76:721-728.
80. Bae EH, Lim SY, Cho KH, et al. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 2012;59:795-802.
81. Choi JS, Kim CS, Bae EH, et al. Predicting outcomes after myocardial infarction by using the Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease study equation: results from the Korea Acute Myocardial Infarction Registry. Nephrol Dial Transplant 2012;27:3868-3874.
82. Choi JS, Kim MJ, Kang YU, et al. Association of age and CKD with prognosis of myocardial infarction. Clin J Am Soc Nephrol 2013;8:939-944.
83. Choi JS, Kim CS, Bae EH, et al. Suboptimal medical care of patients with ST-elevation myocardial infarction and renal insuff iciency: results from the Korea Acute Myocardial Infarction Registry. BMC Nephrol 2012;13:110.
84. Hachinohe D, Jeong MH, Saito S, et al. Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol 2011;108:206-213.
85. Lim SY, Bae EH, Choi JS, et al. Percutaneous coronary intervention for acute myocardial infarction in elderly patients with renal dysfunction: results from the Korea Acute Myocardial Infarction Registry. J Korean Med Sci 2013;28:1027-1033.
86. Piao ZH, Jeong MH, Jin L, et al. Clinical impact of early intervention in octogenarians with non-ST-elevation myocardial infarction. Int J Cardiol 2014;172:462-464.
87. Lee KH, Ahn Y, Kim SS, et al. Characteristics, in-hospital and long-term clinical outcomes of nonagenarian compared with octogenarian acute myocardial infarction patients. J Korean Med Sci 2014;29:527-535.
88. Yamanaka F, Jeong MH, Saito S, et al. Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: analysis of the Korean Acute Myocardial Infarction Registry. J Cardiol 2013;62:210-216.
89. Yoo YP, Kang KW, Yoon HS, et al. One-year clinical outcomes in invasive treatment strategies for acute ST-elevation myocardial infarction complicated by cardiogenic shock in elderly patients. J Geriatr Cardiol 2013;10:235-241.